drugset / Trial / NCT02060019
Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
Non-randomizedCrossoverOpen-labelBasic science
Summary
This study is designated to evaluate the pharmacokinetic interactions of amlodipine besylate, valsartan and rosuvastatin in healthy male volunteers.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-06
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |
Indications
No indication recorded.